Medicxi Bolsters and Expands Team with Senior Industry Leaders

17 March 2020, London, Geneva & Jersey – Medicxi, the leading European life sciences investment firm, today announced the appointment of Sanford (Sandy) Zweifach and Paul Sekhri as Venture Partners.

In their roles at Medicxi, Mr. Zweifach and Mr. Sekhri will leverage their strong track records of successful transactions and respective 30 plus years of experience stewarding life sciences companies  to help steer Medicxi’s  portfolio companies to optimal growth and the best suited strategic transactions,  as a number of molecules in development move to proof of concept stage, or enter the clinic.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...